Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Special Meeting and Acquisition Update

25 Oct 2018 07:00

RNS Number : 1084F
TyraTech, Inc.
25 October 2018
 

Embargoed until: 07.00 on 25th October 2018

 

TYRATECH, INC.

("TyraTech" or the "Company")

Special Meeting and Acquisition Update

The Directors of Tyratech (AIM: TYRU and TYR), give the following update further to the notice issued on the 28 September 2018 relating to the Company's proposed acquisition by American Vanguard Corporation ("AMVAC") at 3.15 pence per Share (the "Transaction").

The Company reminds all shareholders that the deadline for voting is 3 pm (UK) on 30th October 2018 for shares held under nominees, brokers or banks. However, shareholders are advised to check with their nominee or broker, some of whom may have set earlier deadlines for their own administrative reasons. If shareholders hold their shares via a nominee, and not in their own name, they are reminded that their method of voting is to contact the nominee or broker and give specific instructions to vote on their behalf. Those shareholders holding shares in their own name may return their proxy cards by post, fax or email a scanned copy to the Company's Registrars, Computershare: Externalproxyqueries@computershare.co.uk, by 3pm (UK) on 31st October 2018.

Full details may be found in the Proxy Statement issued on 9th October 2018, which is available on the Company's website www.tyratech.com.

Under US Delaware Law, in order for the Transaction to proceed, an overall majority of all the voting stock (not just a majority of those voting) is required to vote in favour. It is therefore very important that all shareholders vote. A non-vote has the same effect as a vote against. A separate vote, requiring a 75% majority of the votes cast is required to approve the cancellation of the Company's trading on AIM (contingent on completion of the Transaction).

The Board continues to recommend that shareholders vote FOR the approval and adoption of the Merger Agreement; and FOR the cancellation of admission of the Company's Common Stock to trading on AIM.

As outlined in the announcement issued on 28th September 2018, should TyraTech shareholders not approve the Transaction, the Independent Directors believe little, if any, cash would be available for return to TyraTech shareholders.

More information about how to vote is available on the Company's website www.tyratech.com If shareholders are unable to access the Company's website, copies of the Proxy Statement and Proxy Form are available from the Company's Registrar, Computershare, c/o The Pavillions, Bridgewater Road, Bristol, BS99 6ZY. They can be contacted on 0370 702 0000 for copies, or 0370 707 4040 with any other questions.

 

-ends-

 

For further information:

 

TyraTech Inc.

Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4340

Erica H. Boisvert, Chief Financial Officer

Tel: +1 919 415 4287

www.tyratech.com

SPARK Advisory Partners Limited (Nominated Adviser)

Matt Davis

Tel: +44 203 368 3550

WH Ireland Limited (Broker)

Adrian Hadden / Chris Viggor

Tel: +44 20 7220 1666

Belvedere Communications (PR)

John West / Kim van Beeck

Tel: +44 20 3687 2756

 

Additional information

This Announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction, including without limitation, the United Kingdom, the United States, Australia, Canada or Japan. Persons needing advice should consult an independent financial adviser.

The distribution of this Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

SPARK Advisory Partners Limited served as exclusive financial advisor to TyraTech and provided a fairness opinion to the Independent Directors. SPARK Advisory Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for the Company and no one else in connection with the Transaction and will not be responsible to anyone other than the Company for providing protections afforded to clients of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ARIFKQDDCBDDFKB
Date   Source Headline
31st Jan 20144:26 pmRNSProposed Placing
23rd Jan 20145:58 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHead-Lice Preventative Shampoo Coming to US Market
14th Jan 20147:00 amRNSChange of Adviser
14th Jan 20147:00 amRNSVamousse coming to Walmart stores in the USA
18th Dec 20137:00 amRNSBlocklisting Interim Review
25th Oct 20132:39 pmRNSDirector/PDMR Shareholding
7th Oct 20138:39 amRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSInterim Results
14th Aug 20137:00 amRNSGlobal distribution agreement for biocide products
25th Jul 20136:11 pmRNSResult of AGM
27th Jun 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSDirectorate Changes
19th Jun 20139:59 amRNSBlocklisting Interim Review
11th Jun 20134:23 pmRNSDirectorate Change
31st May 201312:43 pmRNSMigration of Shares
11th Apr 20137:00 amRNSFrench Registration of Insect Repellent Product
9th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20136:09 pmRNSResult of Special Meeting
28th Mar 20134:15 pmRNSShare Migration
18th Mar 20137:00 amRNSProposed placing and subscription of common shares
4th Mar 20137:00 amRNSUK registration of insect repellent product
4th Feb 20137:00 amRNSFirst Patent Granted for ExtendT Technology
10th Jan 20137:00 amRNSDirectorate Change
7th Jan 201310:40 amRNSNew Anti-Endoparasitic Composition Patents
20th Dec 20127:00 amRNSIssue of Equity
18th Dec 20122:56 pmRNSBlocklisting Interim Review
18th Dec 20127:00 amRNSGerman Registration of Insect Repellent Product
17th Dec 20127:00 amRNSFirst Shipment of Retail Products
11th Dec 20127:00 amRNSHead Lice Product Registration in UK
4th Dec 20127:00 amRNSFormation of New Joint Venture
13th Nov 20127:00 amRNSU.S. Registration of New Insect Repellent Product
30th Oct 20127:00 amRNSAdvance Payment on Prospective New Alliance
29th Oct 20127:00 amRNSChange of Name of Adviser
16th Oct 201211:40 amRNSTyraTech Secures New Patent
16th Oct 20129:26 amRNSMigration of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.